| ACLF | Acute-on chronic liver failure |
| ATX | Autotaxin |
| BBB | Blood–brain barrier |
| CNS | Central nervous system |
| COX2 | Cyclooxygenase 2 |
| CSF | Cerebrospinal fluid |
| DMSO | Dimethylsulfoxide |
| FACS | Fluorescence-activated cell sorting |
| GFAP | Glial fibrillary acidic protein |
| IBA1 | Ionized calcium binding adaptor molecule 1 |
| JNK | c-Jun N-terminale Kinasen |
| LC-MS/MS | Liquid chromatography–mass spectrometry/mass spectometry |
| LDH | Lactate dehydrogenase |
| LPA | Lysophosphatidic acid |
| LPAR | Lysophosphatidic acid receptor |
| LPC | Lysophosphatidyl choline |
| LPS | Lipopolysaccharide |
| MS | Multiple sclerosis |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| NO | Nitric oxide |
| NOS2 | Nitric oxide synthase 2 |
| PLD | Phospholipase D |
| STAT1 | Signal transducer and activator of transcription 1 |
| STAT6 | Signal transducer and activator of transcription 6 |
| TF | Transcription factor |
| TLR4 | Toll-like receptor 4 |
| TRIF | TIR-domain-containing adapter-inducing interferon-β |